Category:pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Melting Point: | 114.00 °C. @ 760.00 mm Hg
|
Boiling Point: | 319.00 °C. @ 760.00 mm Hg
|
Vapor Pressure: | 0.000030 mmHg @ 25.00 °C. (est) |
Flash Point: | 239.00 °F. TCC ( 114.80 °C. ) (est)
|
logP (o/w): | 0.380 |
Soluble in: |
| water, 5.19E+04 mg/L @ 25 °C (exp) | | water, 2.376e+004 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intravenous-cat LDLo 525 mg/kg SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: NAUSEA OR VOMITING Journal of Pharmacology and Experimental Therapeutics. Vol. 39, Pg. 177, 1930.
oral-cat LDLo 1250 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
GASTROINTESTINAL: NAUSEA OR VOMITING Journal of Pharmacology and Experimental Therapeutics. Vol. 39, Pg. 177, 1930.
oral-dog LDLo 500 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1304, 1935.
oral-guinea pig LDLo 1400 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59Vol. 5, Pg. 14, 1959.
unreported-man LDLo 74 mg/kg "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
intraperitoneal-mouse LD50 750 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 135, Pg. 376, 1962.
intravenous-mouse LD50 500 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 10, Pg. 686, 1960.
oral-mouse LD50 1310 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 45, Pg. 137, 1956.
intravenous-rabbit LDLo 600 mg/kg "Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59Vol. 5, Pg. 14, 1959.
oral-rat LD50 1705 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 401, 1959.
|
Dermal Toxicity: |
subcutaneous-cat LDLo 700 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1304, 1935.
subcutaneous-frog LDLo 2000 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1304, 1935.
subcutaneous-guinea pig LDLo 1600 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
CARDIAC: PULSE RATE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 186, Pg. 195, 1937.
subcutaneous-mouse LD50 1000 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 214, 1967.
subcutaneous-rabbit LDLo 1000 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1304, 1935.
subcutaneous-rat LDLo 1570 mg/kg AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC
CARDIAC: OTHER CHANGES Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 186, Pg. 195, 1937.
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | pharmaceuticals / chemical synthisis |
Recommendation for antipyrine usage levels up to: | | not for fragrance use.
|
|
Recommendation for antipyrine flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| analgesine | | anodynin | 3- | antipyrine | | antipyrinum | | auralgan | | azophen | 1,2- | dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one | 2,3- | dimethyl-1-phenyl-3-pyrazolin-5-one | 2,3- | dimethyl-1-phenyl-5-pyrazolone | 1,5- | dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one | 1,5- | dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one | 1,5- | dimethyl-2-phenyl-3-pyrazolone | 1,5- | dimethyl-2-phenylpyrazol-3-one | | dimethyloxyquinazine | | fenazona | | fenazone | | methozin | | parodyne | | phenazon | | phenazone | | phenozone | 1- | phenyl-2,3-dimethyl-5-pyrazolone | 1- | phenyl-2,3-dimethylpyrazole-5-one | | phenyldimethylpyrazolone | | pyramidone | 3H- | pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-2-phenyl- | | pyrazophyl | | sedatin |
Articles:
PubMed:A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. |
PubMed:Rapid enzymatic method for pectin methyl esters determination. |
PubMed:Analysis of the monosaccharide composition of water-soluble polysaccharides from Sargassum fusiforme by high performance liquid chromatography/electrospray ionisation mass spectrometry. |
PubMed:[Rapid identification 15 effective components of anti common cold medicine with MRM by LC-MS/MS]. |
PubMed:The predominance of type I oligosaccharides is a feature specific to human breast milk. |
PubMed:CYP450-dependent biotransformation of the insecticide fipronil into fipronil sulfone can mediate fipronil-induced thyroid disruption in rats. |
PubMed:Transformation of phenazone-type drugs during chlorination. |
PubMed:Passage of 4-nonylphenol across the human placenta. |
PubMed:Acute effects of ethanol on the transfer of nicotine and two dietary carcinogens in human placental perfusion. |
PubMed:Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism. |
PubMed:Transplacental transfer of nitrosodimethylamine in perfused human placenta. |
PubMed:Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta. |
PubMed:Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. |
PubMed:Determination of caffeine and associated compounds in food, beverages, natural products, pharmaceuticals, and cosmetics by micellar electrokinetic capillary chromatography. |
PubMed:Modulation of antipyrine clearance by polysaccharide peptide (PSP) isolated from Coriolus versicolor in the rat. |
PubMed:Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry. |
PubMed:Detection and identification of phenazone-type drugs and their microbial metabolites in ground and drinking water applying solid-phase extraction and gas chromatography with mass spectrometric detection. |
PubMed:Determination of 1-phenyl-3-methyl-5-pyrazolone-labeled carbohydrates by liquid chromatography and micellar electrokinetic chromatography. |
PubMed:[Experience of biologically active supplements to food containing indoles and isothiocyanates in patients with chronic viral hepatitis]. |
PubMed:Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. |
PubMed:Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. |
PubMed:Migraine in older patients: a case report and management strategies. |
PubMed:Endogenous benzodiazepines. |
PubMed:The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function. |
PubMed:Influence of diet and nutritional status on drug metabolism. |
PubMed:Pharmacokinetics of pantoprazole in man. |
PubMed:Pharmacokinetics of pantoprazole in man. |
PubMed:Lack of effect of zinc supplementation on antipyrine clearance in alcoholic liver disease. |
PubMed:Influence of a three-day feed and water deprivation period on gut fill, tissue weights, and tissue composition in mature wethers. |
PubMed:Clinical pharmacokinetics of lansoprazole. |
PubMed:Separation and identification of phase I and phase II [14C]antipyrine metabolites in rat and dog urine. |
PubMed:The effects of Artemisia filifolia and Helenium flexuosum on disposition of antipyrine in rabbits. |
PubMed:The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum. |
PubMed:Clinical pharmacokinetics of ticlopidine. |
PubMed:Pharmacokinetics of antipyrine in calves at neonatal period fed with casein supplemented food. |
PubMed:Clinical pharmacology and pharmacokinetics of oxcarbazepine. |
PubMed:Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat. |
PubMed:Chronic physical activity alters hepatobiliary excretory function in rats. |
PubMed:Pharmacokinetics of dirithromycin. |
PubMed:Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin. |
PubMed:Influence of intact and myrosinase-treated indolyl glucosinolates on the metabolism in vivo of metronidazole and antipyrine in the rat. |
PubMed:Urinary excretion of angiotensin I, II, arginine vasopressin and oxytocin in patients with anaphylactoid reactions. |
PubMed:Clinical pharmacokinetics in veterinary medicine. |
PubMed:Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: cattle, goat, rat and rabbit. |
PubMed:[Effects of zixoryn on pharmacokinetics of antipyrine in intact and sensitized guinea pigs]. |
PubMed:Concurrent bromosulphophthalein and antipyrine administration to assess liver blood flow and hepatic enzymes in rats. |
PubMed:[Evaluation of the inducing action of aroclor 1254 in rats in long-term experiment]. |
PubMed:Effects of endophyte-infected fescue and cimetidine on respiration rates, rectal temperatures and hepatic mixed function oxidase activity as measured by hepatic antipyrine metabolism in sheep. |
PubMed:Effect of subacute oral intake of the food antioxidant butylated hydroxyanisole on clinical parameters and phase-I and -II biotransformation capacity in man. |
PubMed:Pharmacokinetic characteristics of roxatidine. |
PubMed:Effect of trenbolone and testosterone on the plasma elimination rates of sulfamethazine, trimethoprim, and antipyrine in female dwarf goats. |
PubMed:Antipyrine absorption and disposition in the elderly. |
PubMed:Interaction of roxatidine acetate with antacids, food and other drugs. |
PubMed:Pharmacokinetics of roxatidine in healthy volunteers. |
PubMed:[The influence of environmental factors, age, sex and menstrual cycle on the metabolism of drugs in the liver]. |
PubMed:A comparison of the effects of a macrobiotic diet and a Western diet on drug metabolism and plasma lipids in man. |
PubMed:Starvation induced changes in quantitative measures of liver function in the rat. |
PubMed:Effect of the immunomodulator tilorone on antipyrine disposition in the rat. |
PubMed:Antipyrine metabolism in African villagers. |
PubMed:Effects of parenteral nutritional regimens on oxidative drug metabolism. |
PubMed:Heterogeneity of hepatic aryl hydrocarbon hydroxylase activity in feral winter flounder: relevance to carcinogenicity testing. |
PubMed:Clinical pharmacokinetics of labetalol. |
PubMed:Petrol exposure and hepatic enzyme activity. |
PubMed:Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. |
PubMed:Food interactions affecting the absorption of analgesic and anti-inflammatory agents. |
PubMed:Food and drug interactions. |
PubMed:Improved 4-aminoantipyrine colorimetry for detection of residual hydrogen peroxide in noodles, fish paste, dried fish, and herring roe. |
PubMed:Influence of ascorbic acid and erythorbic acid on drug metabolism in the cynomolgus monkey. |
PubMed:Research review. Interactions between environmental chemicals and drug biotransformation in man. |
PubMed:Influence of food on the bioavailability of drugs. |
PubMed:Bioavailability of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): interindividual variation and influence of food intake. |
PubMed:The effect of fasting on the rate of intestinal drug absorption in rats: preliminary studies. |
PubMed:Metabolic interactions among environmental chemicals and drugs. |
|
an analgesic and antipyretic that has been given by mouth and as ear drops. antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (from martindale, the extra pharmacopoeia, 30th ed, p29)
|